Royal Bank of Canada’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,196
| Closed | -$1.46M | – | 7971 |
|
|
2020
Q4 | $1.46M | Sell |
20,196
-99,275
| -83% | -$5.2M | ﹤0.01% | 3200 |
|
|
2020
Q3 | $5.45M | Sell |
119,471
-29,933
| -20% | -$1.25M | ﹤0.01% | 1954 |
|
|
2020
Q2 | $6.75M | Buy |
149,404
+101,673
| +213% | +$4.56M | ﹤0.01% | 1740 |
|
|
2020
Q1 | $1.84M | Buy |
47,731
+37,199
| +353% | +$1.71M | ﹤0.01% | 2549 |
|
|
2019
Q4 | $488K | Buy |
10,532
+3,762
| +56% | +$163K | ﹤0.01% | 4013 |
|
|
2019
Q3 | $275K | Sell |
6,770
-3,487
| -34% | -$151K | ﹤0.01% | 4247 |
|
|
2019
Q2 | $494K | Sell |
10,257
-54,692
| -84% | -$2.88M | ﹤0.01% | 3871 |
|
|
2019
Q1 | $4.07M | Sell |
64,949
-5,171
| -7% | -$355K | ﹤0.01% | 2163 |
|
|
2018
Q4 | $4.19M | Sell |
70,120
-11,027
| -14% | -$662K | ﹤0.01% | 2119 |
|
|
2018
Q3 | $5.23M | Sell |
81,147
-8,137
| -9% | -$454K | ﹤0.01% | 2077 |
|
|
2018
Q2 | $4.02M | Buy |
89,284
+5,317
| +6% | +$212K | ﹤0.01% | 2179 |
|
|
2018
Q1 | $2.61M | Buy |
83,967
+5,886
| +8% | +$194K | ﹤0.01% | 2472 |
|
|
2017
Q4 | $2.34M | Sell |
78,081
-1,539
| -2% | -$44.6K | ﹤0.01% | 2606 |
|
|
2017
Q3 | $2.63M | Buy |
79,620
+31,256
| +65% | +$1.08M | ﹤0.01% | 2452 |
|
|
2017
Q2 | $1.62M | Buy |
48,364
+28,631
| +145% | +$854K | ﹤0.01% | 2755 |
|
|
2017
Q1 | $571K | Sell |
19,733
-111
| -0.6% | -$2.75K | ﹤0.01% | 3536 |
|
|
2016
Q4 | $443K | Buy |
19,844
+616
| +3% | +$12K | ﹤0.01% | 3866 |
|
|
2016
Q3 | $357K | Buy |
19,228
+568
| +3% | +$10.7K | ﹤0.01% | 4000 |
|
|
2016
Q2 | $304K | Sell |
18,660
-1,852
| -9% | -$27.2K | ﹤0.01% | 4093 |
|
|
2016
Q1 | $239K | Sell |
20,512
-2,726
| -12% | -$30.5K | ﹤0.01% | 4248 |
|
|
2015
Q4 | $271K | Buy |
23,238
+4,234
| +22% | +$53.6K | ﹤0.01% | 4313 |
|
|
2015
Q3 | $233K | Buy |
19,004
+17,406
| +1,089% | +$222K | ﹤0.01% | 4195 |
|
|
2015
Q2 | $15K | Sell |
1,598
-12,021
| -88% | -$111K | ﹤0.01% | 5883 |
|
|
2015
Q1 | $121K | Buy |
13,619
+7,441
| +120% | +$75.2K | ﹤0.01% | 4518 |
|
|
2014
Q4 | $62K | Buy |
6,178
+2,578
| +72% | +$22.1K | ﹤0.01% | 4964 |
|
|
2014
Q3 | $24K | Buy |
+3,600
| New | +$25.2K | ﹤0.01% | 5234 |
|
|
2014
Q2 | – | Sell |
-500
| Closed | -$5K | – | 6463 |
|
|
2014
Q1 | $5K | Hold |
500
| – | – | ﹤0.01% | 5596 |
|
|
2013
Q4 | $4K | Buy |
+500
| New | +$4.67K | ﹤0.01% | 5677 |
|
|
2013
Q3 | – | Sell |
-308
| Closed | -$2K | – | 6508 |
|
|
2013
Q2 | $2K | Buy |
+308
| New | +$1.04K | ﹤0.01% | 5674 |
|
Other funds holding BEAT
Royal Bank of Canada's BEAT Position: Q1 2021 in Review
Royal Bank of Canada sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 20,196 shares — an estimated $1.46M sold.
Royal Bank of Canada first reported a position in BEAT in Q2 2013 and held it in 29 quarters. The position peaked at $6.75M in Q2 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Royal Bank of Canada reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Royal Bank of Canada sold 20,196 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.46M.
- Royal Bank of Canada first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 29 quarters.
- Royal Bank of Canada's BioTelemetry, Inc. position peaked at $6.75M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.